Poster Session: Effects of Lomitapide in Patients with HoFH


Marina Cuchel M.D.  Assistant Professor of Medicine at the University of Pennsylvania School of Medicine recently provided Rare Disease Report an exclusive look at her poster presentation of lomitapide's efficacy and safety in patients with homozygous familial hypercholesterolemia.  This data was later published in The Lancet.

For more details of this study, lomitapide, and HoFH, please go to our accompanying article.

Printer Printing...